1 / 41

Zyprexa documents ppt 2.

Zyprexa documents ppt 2. This powerpoint has a selection of pages from documents to do with marketing issues. ZY 100175096 Viva Zyprexa. ZY 100175096 Viva Zyprexa PCPs/GPs = financial opportunities. ZY 100175096 Viva Zyprexa Unmet needs/disease-mongering.

fern
Download Presentation

Zyprexa documents ppt 2.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Zyprexa documents ppt 2. This powerpoint has a selection of pages from documents to do with marketing issues.

  2. ZY 100175096Viva Zyprexa

  3. ZY 100175096 Viva ZyprexaPCPs/GPs = financial opportunities

  4. ZY 100175096 Viva ZyprexaUnmet needs/disease-mongering

  5. ZY 100175096 Viva ZyprexaUnmet needs/disease-mongering

  6. ZY 100175096 Viva ZyprexaUnmet needs/disease-mongering

  7. ZY 100175096 Viva ZyprexaUnmet needs/disease-mongering

  8. ZY 100175096 Viva ZyprexaIncentives to sales reps

  9. ZY 100175096 Viva ZyprexaPhysician type casting & targeting

  10. ZY 100175096 Viva ZyprexaPhysician CME strategy

  11. ZY 100175096 Viva ZyprexaHave the “customers” got the message?

  12. ZY 100175096 Viva Zyprexastudying and utilising the “customers”

  13. To the tune of “Viva Las Vegas” ZY 100175096 Viva Zyprexa

  14. ZY100040517 Primary Care sales video

  15. ZY100040517 Primary Care sales video

  16. ZY100040517 Primary Care sales video

  17. ZY100040517 Primary Care sales video

  18. ZY100040668 PCP strategy manual

  19. ZY100040668 PCP strategy manual

  20. ZY100040668 PCP strategy manual

  21. ZY100040668 PCP strategy manual

  22. ZY100040668 PCP strategy manual

  23. ZY200307990 Lilly exec comments to media re off-label marketing dwarfing schizophrenia opportunities plus media comments re CME newspaper article Mar 2003

  24. ZY200307990 Lilly exec comments to media re off-label marketing dwarfing schizophrenia opportunities plus media comments re CME newspaper article Mar 2003

  25. ZY200307990 Lilly exec comments to media re off-label marketing dwarfing schizophrenia opportunities plus media comments re CME newspaper article Mar 2003

  26. ZY200307990 Lilly exec comments to media re off-label marketing dwarfing schizophrenia opportunities plus media comments re CME newspaper article Mar 2003

  27. ZY100520636 Primary care implementation guide June 2001

  28. ZY100520636 Primary care implementation guide June 2001

  29. ZY100520636 Primary care implementation guide June 2001

  30. ZY100520636 Primary care implementation guide June 2001

  31. ZY100520636 Primary care implementation guide June 2001

  32. ZY100520636 Primary care implementation guide June 2001

  33. ZY100520636 Primary care implementation guide June 2001

  34. ZY201220087 APA 2002 preparation

  35. ZY201220087 APA 2002 preparation

  36. ZY201220087 APA 2002 preparation

  37. ZY201220087 APA 2002 preparation

  38. ZY201220087 APA 2002 preparation

  39. ZY201558654 “Competitive literature review” May 2002 • Document includes numerous studies by independent researchers and competitor pharma companies re hypergylcaemia, diabetes and hyperlipidaemia. • Are “reviewed” in (hyper)critical manner to be found in error. • Underlying theory seems to be Zyprexa can’t cause these problems.

  40. ZY201220087 APA 2002 preparation

  41. ZY100014182 APA 2003 review

More Related